• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢克肟口腔崩解片中超级崩解剂的处方开发、评价及效果比较研究

Formulation development, evaluation and comparative study of effects of super disintegrants in cefixime oral disintegrating tablets.

作者信息

Remya Ks, Beena P, Bijesh Pv, Sheeba A

机构信息

Nazareth College of Pharmacy, Othera P.O, Thiruvalla, Pathanamthitta (Dist.), Kerala - 689 546, India.

出版信息

J Young Pharm. 2010 Jul;2(3):234-9. doi: 10.4103/0975-1483.66794.

DOI:10.4103/0975-1483.66794
PMID:21042477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2964761/
Abstract

The present work was aimed at formulation development, evaluation and comparative study of the effects of superdisintegrants in Cefixime 50 mg oral disintegrating tablets. The superdisintegrants used for the present study were sodium starch glycolate and crosscarmellose sodium. The formulated tablets were evaluated for various tableting properties, like hardness, thickness, friability, weight variation, disintegration time and dissolution rate. Comparative evaluation of the above-mentioned parameters established the superiority of the tablets formulated with crosscarmellose sodium to those formulated with sodium starch glycolate.

摘要

本研究旨在开发头孢克肟50mg口腔崩解片的处方,评估超级崩解剂的效果并进行对比研究。本研究中使用的超级崩解剂为羟丙甲纤维素和交联羧甲基纤维素钠。对制得的片剂进行了多种压片性能评估,如硬度、厚度、脆碎度、重量差异、崩解时间和溶出速率。对上述参数的对比评估证实,用交联羧甲基纤维素钠制得的片剂优于用羟丙甲纤维素制得的片剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/1ae5a34747be/JYPharm-2-234-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/92f2a2559a01/JYPharm-2-234-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/3febb82c0a78/JYPharm-2-234-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/939c0a06be25/JYPharm-2-234-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/2faab7de6372/JYPharm-2-234-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/255c8b125c91/JYPharm-2-234-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/88fb9948777d/JYPharm-2-234-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/1ae5a34747be/JYPharm-2-234-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/92f2a2559a01/JYPharm-2-234-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/3febb82c0a78/JYPharm-2-234-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/939c0a06be25/JYPharm-2-234-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/2faab7de6372/JYPharm-2-234-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/255c8b125c91/JYPharm-2-234-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/88fb9948777d/JYPharm-2-234-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253c/2964761/1ae5a34747be/JYPharm-2-234-g007.jpg

相似文献

1
Formulation development, evaluation and comparative study of effects of super disintegrants in cefixime oral disintegrating tablets.头孢克肟口腔崩解片中超级崩解剂的处方开发、评价及效果比较研究
J Young Pharm. 2010 Jul;2(3):234-9. doi: 10.4103/0975-1483.66794.
2
Formulation of Ebastine Fast-Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters.采用共处理超高效崩解剂的依巴斯汀速崩片的制剂及质量控制参数的评价。
ScientificWorldJournal. 2022 May 19;2022:9618344. doi: 10.1155/2022/9618344. eCollection 2022.
3
Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants.速崩解非诺维林片的处方设计与评价:超级崩解剂的作用
Drug Dev Ind Pharm. 2007 Nov;33(11):1225-32. doi: 10.1080/03639040701377888.
4
A Comparative Study of Different Proportions of Superdisintegrants: Formulation and Evaluation of Orally Disintegrating Tablets of Salbutamol Sulphate.不同比例超级崩解剂的比较研究:硫酸沙丁胺醇口腔崩解片的处方设计与评价
Turk J Pharm Sci. 2017 Apr;14(1):40-48. doi: 10.4274/tjps.74946. Epub 2017 Apr 15.
5
Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.羟丙甲纤维素、交联羧甲基纤维素钠和交联聚维酮对甜菊糖苷片崩解和溶出的影响。
Polim Med. 2019 Jan-Jun;49(1):19-26. doi: 10.17219/pim/111516.
6
Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate for respiratory disorders.用于呼吸系统疾病的硫酸沙丁胺醇口腔崩解片的处方开发与评价
ISRN Pharm. 2013 Jul 15;2013:674507. doi: 10.1155/2013/674507. eCollection 2013.
7
Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum.草药速崩片的制剂及其在豚鼠回肠中抗组胺活性的体外研究。
Curr Clin Pharmacol. 2018;13(2):128-135. doi: 10.2174/1574884713666180309153942.
8
Formulation and characterization of oral rapid disintegrating tablets of levocetirizine.左西替利嗪口腔速崩片的处方设计与表征
Polim Med. 2018 Jan-Jun;48(1):31-40. doi: 10.17219/pim/99951.
9
Formulation Development and Evaluation of Fast Disintegrating Tablet of Cetirizine Hydrochloride: A Novel Drug Delivery for Pediatrics and Geriatrics.盐酸西替利嗪口腔崩解片的处方工艺开发与评价:一种适用于儿科和老年科的新型给药方式
J Pharm (Cairo). 2014;2014:808167. doi: 10.1155/2014/808167. Epub 2014 Feb 18.
10
Formulation and evaluation of mouth disintegrating tablets of atenolol and atorvastatin.阿替洛尔和阿托伐他汀口腔崩解片的处方设计与评价
Indian J Pharm Sci. 2015 Jan-Feb;77(1):83-90. doi: 10.4103/0250-474x.151602.

引用本文的文献

1
Development and characterisation of orally disintegrating flurbiprofen tablets using SeDeM-ODT tool.采用 SeDeM-ODT 工具研制和表征速崩型氟比洛芬片剂。
PLoS One. 2024 Oct 29;19(10):e0309894. doi: 10.1371/journal.pone.0309894. eCollection 2024.
2
Revolutionizing fast disintegrating tablets: Harnessing a dual approach with porous starch and sublimation technique.革新速崩片:采用多孔淀粉与升华技术的双重方法。
Heliyon. 2024 Oct 2;10(19):e38793. doi: 10.1016/j.heliyon.2024.e38793. eCollection 2024 Oct 15.
3
A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation.

本文引用的文献

1
Plantago ovata Mucilage in the Design of Fast Disintegrating Tablets.速崩片设计中的车前子黏液质
Indian J Pharm Sci. 2009 Jan;71(1):41-5. doi: 10.4103/0250-474X.51952.
2
The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime.单次口服头孢克肟治疗咽淋病。
Int J STD AIDS. 2007 Apr;18(4):253-4. doi: 10.1258/095646207780658971.
固定剂量利福平与吡嗪酰胺的微配置多颗粒可重构悬浮粉末:优化制备及体外质量评价
Pharmaceutics. 2022 Dec 25;15(1):64. doi: 10.3390/pharmaceutics15010064.
4
Process Model Approach to Predict Tablet Weight Variability for Direct Compression Formulations at Pilot and Production Scale.中试和生产规模下直接压片制剂片剂重量变异预测的过程模型方法
Pharmaceutics. 2021 Jul 7;13(7):1033. doi: 10.3390/pharmaceutics13071033.
5
Orally-disintegrating Tablets in Fixed-dose Combination Containing Ambroxol Hydrochloride and Salbutamol Sulphate Prepared by Direct Compression: Formulation Design, Development and Evaluation.直接压片法制备的含盐酸氨溴索和硫酸沙丁胺醇的复方口腔崩解片:处方设计、研发与评价
Turk J Pharm Sci. 2018 Apr;15(1):29-37. doi: 10.4274/tjps.24633. Epub 2018 Apr 2.
6
A Comprehensive Study on Fast Dispersible and Slow-Releasing Characteristic of Orange Peel Pectin in Relation to Established Synthetic Polymer.橙皮果胶与现有合成聚合物相关的快速分散和缓释特性的综合研究。
Pharmacogn Mag. 2017 Oct;13(Suppl 3):S401-S404. doi: 10.4103/pm.pm_193_17. Epub 2017 Oct 11.
7
Alginate-Based Composite Sponges as Gastroretentive Carriers for Curcumin-Loaded Self-Microemulsifying Drug Delivery Systems.基于海藻酸盐的复合海绵作为载姜黄素自微乳化药物递送系统的胃滞留载体
Sci Pharm. 2017 Mar 15;85(1):11. doi: 10.3390/scipharm85010011.
8
Development and Evaluation of Taste Masked Granular Formulation of Satranidazole by Melt Granulation Technique.通过熔融制粒技术开发和评估沙硝唑掩味颗粒制剂
J Pharm (Cairo). 2014;2014:789676. doi: 10.1155/2014/789676. Epub 2014 Feb 12.
9
Formulation and optimization of fast dissolving intraoral drug delivery system for clobazam using response surface methodology.使用响应面法对氯巴占口腔速溶给药系统进行制剂研发与优化。
J Adv Pharm Technol Res. 2013 Jul;4(3):151-9. doi: 10.4103/2231-4040.116785.
10
Effect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tablets.崩解机制对口腔崩解片的润湿性、吸水性及崩解时间的影响
J Young Pharm. 2012 Jul;4(3):157-63. doi: 10.4103/0975-1483.100021.